Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
STE logo

STERIS Revenues Surge 9.9% Amid Strong Service Demand

STE10-QFiling Date: 11/7/2025
STERIS plc
Description

What this story covers

STERIS plc's Q2 fiscal 2026 10-Q shows 9.9% revenue growth to $1.46B, driven by services and consumables in Healthcare, AST, and Life Sciences segments. Operating income up 21.1%, cash flow at $708M, with debt reduction and strategic focus post-Dental divestiture. Backlog signals demand; risks managed via hedges.

Story snapshot

CompanySTERIS plc
TickerSTE
VariantStandard detailed
Duration10:31
Filing type10-Q
PeriodQ2 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-25-050160

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in